Catalyst Wire Dossier Catalyst Wire Dossier

EGFR-TKI

EGFR tyrosine kinase inhibitor
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for EGFR-TKI, covering 2014-09-26 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLC

See pricing